The FDA launched its PreCheck Pilot program to strengthen domestic pharmaceutical manufacturing by providing earlier facility-focused feedback to selected companies before applications are filed. The pilot uses a two-phase approach, with early technical guidance during facility readiness and streamlined inspections during formal application review, though it does not guarantee faster approvals.